2024

• Cain, L., Bateman, C., Mirochnik, O., Stevens, M., Kellie, S., Padhye, B., Keogh, S., Govender, D., Ryan, J., Dalla Pozza, L. (2024). Low-Level BCR::ABL1 Transcript at Diagnosis in Childhood Leukemia: A 10-Year Single Institution Study. Genes Chromosomes and Cancer, 63(9), e23269. [More Information]

2023

• Trinder, S., McKay, C., Power, P., Topp, M., Chan, B., Valvi, S., McCowage, G., Govender, D., Kirby, M., Ziegler, D., Kellie, S., Sim, H., Kong, B., et al (2023). BRAF-mediated brain tumors in adults and children: A review and the Australian and New Zealand experience. Frontiers in Oncology, 13. [More Information]

2022

• Tong, J., Powys, M., Phan, T., Krivanek, M., Kellie, S., Tumuluri, K. (2022). Pediatric Subcutaneous Panniculitis-like T-cell Lymphoma of the Orbit. Ophthalmic Plastic and Reconstructive Surgery, 38(2), E38-E41. [More Information]

2021

• Gajjar, A., Robinson, G., Smith, K., Lin, T., Merchant, T., Chintagumpala, M., Mahajan, A., Su, J., Bouffet, E., Bartels, U., Kellie, S., McCowage, G., et al (2021). Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03). Journal of Clinical Oncology, 39(7), 822-835. [More Information]
• Robertson, E., Wakefield, C., Tsoli, M., Kellie, S., Alvaro, F., Gifford, A., Weber, M., Rodriguez, M., Kirby, M., Ziegler, D. (2021). Parents' experiences of postmortem tumor donation for high-grade gliomas: Benefits and suggested improvements. Neuro-Oncology Advances, 3(1), vdab087. [More Information]

2020

• Jessop, S., Crudgington, D., London, K., Kellie, S., Howman-Giles, R. (2020). FDG PET-CT in pediatric Langerhans cell histiocytosis. Pediatric Blood and Cancer, 67(1), e28034. [More Information]
• Liu, A., Gudenas, B., Lin, T., Orr, B., Klimo, P., Kumar, R., Bouffet, E., Gururangan, S., Crawford, J., Kellie, S., et al (2020). Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials. Acta Neuropathologica, 139(2), 259-271. [More Information]

2017

• Ghaoui, R., St. Heaps, L., Hung, D., Nagabushan, S., Harris, C., Mirochnik, O., Sharma, P., Kellie, S., Wright, D. (2017). A Paediatric Acute Promyelocytic Leukaemia Patient Harbouring a Cryptic PML-RARA Insertion due to a Complex Structural Chromosome 17 Rearrangement. Cytogenetic and Genome Research, 153(4), 181-189. [More Information]
• Nayak, A., McDowell, D., Kellie, S., Karpelowsky, J. (2017). Elevated Preoperative Neutrophil–Lymphocyte Ratio is Predictive of a Poorer Prognosis for Pediatric Patients with Solid Tumors. Annals of Surgical Oncology, 24(11), 3456-3462. [More Information]

2016

• Gupta, A., Charlton, A., Prelog, K., Kellie, S. (2016). Beta-HCG Elevation in Wilms Tumor: An Uncommon Presentation. Pediatric Blood and Cancer, 63(6), 1105-1106. [More Information]
• Kao, Y., Sung, Y., Zhang, L., Huang, S., Argani, P., Chung, C., Graf, N., Wright, D., Kellie, S., Agaram, N., et al (2016). Recurrent BCOR Internal Tandem Duplication and YWHAE-NUTM2B Fusions in Soft Tissue Undifferentiated Round Cell Sarcoma of Infancy: Overlapping Genetic Features With Clear Cell Sarcoma of Kidney. The American Journal of Surgical Pathology, 40(8), 1009-1020. [More Information]

2015

• Greenop, K., Miller, M., Bailey, H., de Klerk, N., Attia, J., Kellie, S., Bower, C., Armstrong, B., Milne, E. (2015). Childhood folate, B6, B12, and food group intake and the risk of childhood brain tumors: results from an Australian case-control study. Cancer Causes and Control, 26(6), 871-879. [More Information]
• Kalra, M., Heath, J., Kellie, S., Dalla Pozza, L., Stevens, M., Swamy, S., McCowage, G. (2015). Confirmation of Bevacizumab Activity, and Maintenance of Efficacy in Retreatment After Subsequent Relapse, in Pediatric Low-grade Glioma. Journal of Pediatric Hematology / Oncology, 37(6), e341-e346. [More Information]

2014

• Yadav, S., Rastogi, N., Kharya, G., Misra, R., Ramzan, M., Katewa, S., Dua, V., Bhat, S., Kellie, S., Howard, S. (2014). Barriers to cure for children with cancer in India and strategies to improve outcomes: a report by the Indian Pediatric Hematology Oncology Group. Pediatric Hematology and Oncology, 31(3), 217-224. [More Information]

2013

• Peters, S., Glass, D., Reid, A., de Klerk, N., Armstrong, B., Kellie, S., Ashton, L., Milne, E., Fritschi, L. (2013). Parental occupational exposure to engine exhausts and childhood brain tumors. International Journal of Cancer, 132(12), 2975-2979. [More Information]

2012

• Howman-Giles, R., McCowage, G., Kellie, S., Graf, N. (2012). Extrarenal malignant rhabdoid tumor in childhood application of 18F-FDG PET/CT. Journal of Pediatric Hematology / Oncology, 34(1), 17-21. [More Information]

2010

• Zhong, J., Paul, A., Kellie, S., O'Neill, G. (2010). Mesenchymal Migration as a Therapeutic Target in Glioblastoma. Journal of Oncology, 2010 (430142), 430142-1-430142-17. [More Information]
• da Silva, N., Cappellano, A., Diez, B., Cavalheiro, S., Gardner, S., Wisoff, J., Kellie, S., Parker, R., Garvin, J., Finlay, J. (2010). Primary Chemotherapy for Intracranial Germ Cell Tumors: Results of the Third International CNS Germ Cell Tumor Study. Pediatric Blood and Cancer, 54(3), 377-383. [More Information]

2008

• Kellie, S., Howard, S. (2008). Global child health priorities: What role for paediatric oncologists? European Journal of Cancer, 44(16), 2388-96. [More Information]
• Merchant, T., Kun, L., Krasin, M., Wallace, D., Chintagumpala, M., Woo, S., Ashley, D., Sexton, M., Kellie, S., Ahern, V., et al (2008). Multi-Institution Prospective Trial of Reduced-Dose Craniospinal Irradiation (23.4 Gy) Followed by Conformal Posterior Fossa (36 Gy) and Primary Site Irradiation (55.8 Gy) and Dose-Intensive Chemotherapy for Average-Risk Medulloblastoma. International Journal of Radiation: Oncology - Biology - Physics, 70(3), 782-787. [More Information]
• Howman-Giles, R., Holland, A., Mihm, D., Montfort, J., Arbuckle, S., Kellie, S. (2008). Somatic malignant transformation in a sacrococcygeal teratoma in a child and the use of F18FDG PET imaging. Pediatric Surgery International, 24(4), 475-478. [More Information]
• Kim, A., Ji, L., Balmaceda, C., Diez, B., Kellie, S., Dunkel, I., Gardner, S., Sposto, R., Finlay, J. (2008). The Prognostic Value of Tumor Markers in Newly Diagnosed Patients With Primary Central Nervous System Germ Cell Tumors. Pediatric Blood and Cancer, 51(6), 768-773. [More Information]

2007

• Darwish, B., Arbuckle, S., Kellie, S., Besser, M., Chaseling, R. (2007). Desmoplastic infantile ganglioglioma/astrocytoma with cerebrospinal metastasis. Journal of Clinical Neuroscience, 14(5), 498-501. [More Information]

2006

• Thompson, M., Fuller, C., Hogg, T., Dalton, J., Finkelstein, D., Lau, C., Chintagumpala, M., Adesina, A., Ashley, D., Kellie, S., et al (2006). Genornics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. Journal of Clinical Oncology, 24(12), 1924-1931. [More Information]
• Gajjar, A., Chintagumpala, M., Kellie, S., Kun, L., Ashley, D., Merchant, T., Woo, S., Wheeler, G., Ahern, V., Krasin, M., et al (2006). Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. The Lancet Oncology, 7(10), 813-820. [More Information]

2005

• Coakley, J., Kellie, S., Nath, C., Munas, A., Cooke-Yarborough, C. (2005). Interpretation of alpha-fetoprotein concentrations in cerebrospinal fluid of infants. Annals of Clinical Biochemistry, 42(Pt 1), 24-29. [More Information]
• Kellie, S., Chaku, J., Lockwood, L., O'Regan, P., Waters, K., Wong, C. (2005). Late magnetic resonance imaging features of leukoencephalopathy in children with central nervous system tumours following high-dose methotrexate and neuraxis radiation therapy. European Journal of Cancer, 41(11), 1588-1596. [More Information]
• Sastry, J., Kellie, S. (2005). Severe neurotoxicity, ototoxicity and nephrotoxicity following high-dose cisplatin and amifostine. Pediatric Hematology and Oncology, 22(5), 441-445. [More Information]

2004

• Cornwall, P., Murdoch, B., Ward, E., Kellie, S. (2004). Acoustic Investigation Of Vocal Quality Following Treatment For Childhood Cerebellar Tumour. Folia Phoniatrica et Logopaedica, 56(2), 93-107. [More Information]
• Gajjar, A., Hernan, R., Kocak, M., Fuller, C., Lee, Y., McKinnon, P., Wallace, D., Lau, C., Chintagumpala, M., Ashley, D., Kellie, S., et al (2004). Clinical, Histopathologic, And Molecular Markers Of Prognosis: Toward A New Disease Risk Stratification System For Medulloblastoma. Journal of Clinical Oncology, 22(6), 984-993. [More Information]
• Kellie, S., Koopmans, P., Earl, J., Nath, C., Roebuck, D., Uges, D., de Graaf, S. (2004). Increasing The Dosage Of Vincristine: A Clinical And Pharmacokinetic Study Of Continuous-Infusion Vincristine In Children With Central Nervous System Tumors. Cancer, 100(12), 2637-2643. [More Information]
• Kellie, S., Boyce, H., Dunkel, I., Diez, B., Rosenblum, M., Brualdi, L., Finlay, J. (2004). Intensive Cisplatin And Cyclophosphamide-Based Chemotherapy Without Radiotherapy For Intracranial Germinomas: Failure Of A Primary Chemotherapy Approach. Pediatric Blood and Cancer, 43(2), 126-133. [More Information]
• Kellie, S., Boyce, H., Dunkel, I., Diez, B., Rosenblum, M., Brualdi, L., Finlay, J. (2004). Primary Chemotherapy For Intracranial Nongerminomatous Germ Cell Tumors: Results Of The Second International Cns Germ Cell Study Group Protocol. Journal of Clinical Oncology, 22(1), 846-853. [More Information]
• Stewart, C., Iacono, L., Chintagumpala, M., Kellie, S., Ashley, D., Zamboni, W., Kirstein, M., Fouladi, M., Seele, L., Wallace, D., et al (2004). Results Of A Phase Ii Upfront Window Of Pharmacokinetically Guided Topotecan In High-Risk Medulloblastoma And Supratentorial Primitive Neuroectodermal Tumor. Journal of Clinical Oncology, 22(16), 3357-3365. [More Information]
• Kellie, S. (2004). Serum Markers In Tumour Diagnosis And Treatment. In PN Plowman, R Pieters, CR Pinkerton (Eds.), Paediatric Oncology - Clinical Practice and Controversies, (pp. 169-188). United Kingdom: Hodder Education.
• Fouladi, M., Chintagumpala, M., Laningham, F., Ashley, D., Kellie, S., Langston, J., McCluggage, C., Woo, S., Kocak, M., Krull, K., et al (2004). White Matter Lesions Detected By Magnetic Resonance Imaging After Radiotherapy And High-Dose Chemotherapy In Children With Medulloblastoma Or Primitive Neuroectodermal Tumor. Journal of Clinical Oncology, 22(22), 4551-4560. [More Information]

2003

• Cornwell, P., Murdoch, B., Ward, E., Kellie, S. (2003). Perceptual evaluation of motor speech following treatment for childhood cerebellar tumour. Clinical Linguistics and Phonetics, 17(8), 597-615. [More Information]